Gilead Sciences Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 29.5% | 13.5% | 9.2% |
| FY2022 | 21.6% | 10.4% | 7.3% |
| FY2023 | 24.8% | 12.3% | 9.1% |
| FY2024 | 2.5% | 1.1% | 0.8% |
| FY2025 | 37.5% | 19.0% | 14.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 29.5% | 13.5% | 9.2% |
| FY2022 | 21.6% | 10.4% | 7.3% |
| FY2023 | 24.8% | 12.3% | 9.1% |
| FY2024 | 2.5% | 1.1% | 0.8% |
| FY2025 | 37.5% | 19.0% | 14.4% |